Nautilus Biotechnology News

Nautilus Biotechnology Price Target Cut to $1.75/Share From $2.25 by Goldman Sachs

Dow JonesDec 6, 2024 01:53

Nautilus Biotechnology Analyst Ratings

BenzingaDec 6, 2024 01:43

Goldman Sachs Downgrades Nautilus Biotechnology(NAUT.US) to Sell Rating

Futu NewsDec 6, 2024 01:36

Morgan Stanley Maintains Nautilus Biotechnology(NAUT.US) With Hold Rating, Maintains Target Price $5

Futu NewsOct 31, 2024 21:31

Morgan Stanley Maintains Nautilus Biotechnology(NAUT.US) With Hold Rating, Maintains Target Price $5

Futu NewsOct 31, 2024 10:32

TD Cowen Maintains Nautilus Biotechnology(NAUT.US) With Buy Rating

Futu NewsOct 30, 2024 20:33

TD Cowen Maintains Nautilus Biotechnology(NAUT.US) With Buy Rating

Futu NewsOct 30, 2024 06:31

TD Cowen Maintains Nautilus Biotechnology(NAUT.US) With Buy Rating

Futu NewsJul 31, 2024 20:35

Morgan Stanley Maintains Nautilus Biotechnology(NAUT.US) With Hold Rating, Maintains Target Price $5

Futu NewsJul 31, 2024 20:33

TD Cowen Maintains Nautilus Biotechnology(NAUT.US) With Buy Rating

Futu NewsJul 31, 2024 08:31

Nautilus Biotechnology Analyst Ratings

BenzingaJun 27, 2024 19:10

Guggenheim Initiates Coverage On Nautilus Biotechnology With Buy Rating, Announces Price Target of $6

BenzingaJun 27, 2024 19:10

Nautilus Biotechnology Analyst Ratings

BenzingaJun 4, 2024 02:20

Jefferies Assumes Nautilus Biotechnology at Hold, Lowers Price Target of $3

BenzingaJun 4, 2024 02:20

Nautilus Biotechnology Inc.: Jefferies assumes the insured amount is a position and buy rating; target share price is $3 to $5

Zhitong FinanceJun 3, 2024 14:12

Morgan Stanley Reiterates Equal-Weight on Nautilus Biotechnology, Maintains $6 Price Target

BenzingaAug 3, 2023 23:22

Nautilus Biotechnology Analyst Ratings

BenzingaAug 3, 2023 23:21